Get started
Author

Agathe León

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
2019 · Alison J Rodger, Valentina Cambiano, et al. · The Lancet · 1,018
PDF
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients
2004 · Montserrat Laguno, Javier Murillas, et al. · AIDS · 387
A Dendritic Cell–Based Vaccine Elicits T Cell Responses Associated with Control of HIV-1 Replication
2013 · Felipe García, Nuria Climent, et al. · Science Translational Medicine · 220
Feasibility and Effectiveness of Indicator Condition-Guided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study)
2013 · Ann K. Sullivan, Dorthe Raben, et al. · PLoS ONE · 210
PDF
Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy
2005 · Anna Suy, Esteban Martínez, et al. · AIDS · 197
A Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection
2011 · Felipe García, Núria Climent, et al. · The Journal of Infectious Diseases · 133
PDF
Incidence and causes of death in HIV‐infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area
2007 · E Martínez, A Milinkovic, et al. · HIV Medicine · 120
A New Multidisciplinary Home Care Telemedicine System to Monitor Stable Chronic Human Immunodeficiency Virus-Infected Patients: A Randomized Study
2011 · Agathe León, César Cáceres, et al. · PLoS ONE · 87
PDF
Rate and predictors of progression in elite and viremic HIV-1 controllers
2016 · Agathe Leon, Ignacio Perez, et al. · AIDS · 84
Risk of Metabolic Abnormalities in Patients Infected with HIV Receiving Antiretroviral Therapy that Contains Lopinavir‐Ritonavir
2004 · Esteban Martínez, Pere Domingo, et al. · Clinical Infectious Diseases · 82
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)
2011 · Felipe García, Juan Carlos López Bernaldo de Quirós, et al. · Vaccine · 81
PDF
Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection
2017 · María Pernas, Laura Tarancón-Diez, et al. · Journal of Virology · 79
PDF
The Impact of Reducing Stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients
2007 · Ana Milinkovic, Esteban Martinez, et al. · Antiviral Therapy · 76
PDF
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1
2015 · Beatriz Mothe, Nuria Climent, et al. · Journal of Antimicrobial Chemotherapy · 66
Therapeutic vaccines against HIV infection
2012 · Felipe García, Agathe León, et al. · Human Vaccines & Immunotherapeutics · 66
PDF
Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell counts*
2008 · E De Lazzari, A León, et al. · HIV Medicine · 61
PDF
Dendritic cell based vaccines for HIV infection
2013 · Felipe García, Montserrat Plana, et al. · Human Vaccines & Immunotherapeutics · 60
PDF
Early Virological Failure with a Combination of Tenofovir, Didanosine and Efavirenz
2005 · Daniel Podzamczer, Elena Ferrer, et al. · Antiviral Therapy · 58
Differential MicroRNA Expression Profile between Stimulated PBMCs from HIV-1 Infected Elite Controllers and Viremic Progressors
2014 · Lander Egaña-Gorroño, Tuixent Escribà, et al. · PLoS ONE · 55
PDF
Early virological failure in treatment-naive HIV-infected adults receiving didanosine and tenofovir plus efavirenz or nevirapine
2005 · Agathe León, Esteban Martinez, et al. · AIDS · 55
Analysis of Non-AIDS-Defining Events in HIV Controllers
2016 · Beatriz Dominguez-Molina, Agathe Leon, et al. · Clinical Infectious Diseases · 47
Incidence and Risk Factors for Mitochondrial Toxicity in Treated HIV/HCV-Coinfected Patients
2005 · Montse Laguno, Ana Milinkovic, et al. · Antiviral Therapy · 45
PDF
Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients
2010 · Alba Diaz, Llúcia Alós, et al. · AIDS · 44
Increased α-Defensins 1-3 Production by Dendritic Cells in HIV-Infected Individuals Is Associated with Slower Disease Progression
2010 · Marta Rodríguez-García, Núria Climent, et al. · PLoS ONE · 44
PDF
Rate and Predictors of Non-AIDS Events in a Cohort of HIV-Infected Patients with a CD4 T Cell Count Above 500 Cells/mm 3
2013 · Constanza Lucero, Berta Torres, et al. · AIDS Research and Human Retroviruses · 42
Works count: 104
Citation count: 5,354
H-index: 32
I10-index: 58
Year
Topic
Type